The gush of second quarter earnings reports is beginning to slow to a trickle, and with most of the reports in, the results ...

S&P500 holds flat as traders eye Fed’s rate decision, strong GDP data, and Big Tech earnings. Market sentiment hinges on ...

SERB Pharmaceuticals plans to buy Y-mAbs Pharmaceuticals in a $412 million all-cash deal. CorMedix bought Melinta ...

Volatility: Blue chip stocks are usually less volatile than other stocks.

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

The FTSE 100 began Friday’s session on a positive note, gaining 23 points, reaching 9,124, as investors paid attention to ...

Tan’s venture capital firm, based in San Francisco, has made significant investments in Chinese tech companies, including Semiconductor Manufacturing International Corp (SMIC), China's largest chip ...

Pfizer Inc. (NYSE: PFE) delivered a stronger-than-anticipated second-quarter performance, beating analyst estimates and ...

Pfizer Inc. (NYSE:PFE) is one of the Most Undervalued Long Term Stocks to Buy According to Hedge Funds. On August 5, the ...

Eli Lilly reported $15.56bn in revenue, driven by its weight loss and diabetes drugs, intensifying pressure on rival Novo ...

The outgoing CEO’s final financial update highlighted the key issues facing his successor come their September 1 handover, ...

Detailed price information for Arbutus Biopharma Corp (ABUS-Q) from The Globe and Mail including charting and trades.